Shelley Shapiro

6.6k total citations · 2 hit papers
65 papers, 4.0k citations indexed

About

Shelley Shapiro is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Shelley Shapiro has authored 65 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 35 papers in Cardiology and Cardiovascular Medicine and 8 papers in Genetics. Recurrent topics in Shelley Shapiro's work include Pulmonary Hypertension Research and Treatments (42 papers), Cardiovascular Issues in Pregnancy (11 papers) and Heart Failure Treatment and Management (10 papers). Shelley Shapiro is often cited by papers focused on Pulmonary Hypertension Research and Treatments (42 papers), Cardiovascular Issues in Pregnancy (11 papers) and Heart Failure Treatment and Management (10 papers). Shelley Shapiro collaborates with scholars based in United States, Australia and Canada. Shelley Shapiro's co-authors include Nazzareno Galiè, Robyn J. Barst, Adaani Frost, Arnold S. Bayer, Leonard E. Ginzton, Ronald J. Oudiz, Lyn R. Frumkin, Bruce H. Brundage, David B. Badesch and David Langleben and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Shelley Shapiro

61 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tadalafil Therapy for Pulmonary Arterial Hypertension

2009 794 citations Nazzareno Galiè, Bruce H. Brundage et al. Circulation profile →
Sitaxsentan Therapy for Pulmonary Arterial Hypertension

2003 540 citations Robyn J. Barst, David Langleben et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers

Countries citing papers authored by Shelley Shapiro

Since Specialization

Citations

This map shows the geographic impact of Shelley Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shelley Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shelley Shapiro more than expected).

Fields of papers citing papers by Shelley Shapiro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shelley Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shelley Shapiro. The network helps show where Shelley Shapiro may publish in the future.

Co-authorship network of co-authors of Shelley Shapiro

This figure shows the co-authorship network connecting the top 25 collaborators of Shelley Shapiro. A scholar is included among the top collaborators of Shelley Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shelley Shapiro. Shelley Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension 2025 ·Respiratory Medicine ·Sandeep Sahay, Harold I. Palevsky, Karim El‐Kersh, Ricardo Restrepo‐Jaramillo, Abubakr Bajwa, (unknown), (unknown), Leslie Spikes, Michael Eggert, Shilpa Johri, Shelley Shapiro, Micah R. Fisher, Trushil Shah, Gautam Ramani, J.P. Mehta, (unknown), C. Q. Deng, Peter Smith, Meredith Broderick, Charles D. Burger	0
2	Treatment With Oral or Inhaled Treprostinil in Patients With Pulmonary Arterial Hypertension and Cardiovascular Comorbidities 2024 ·CHEST Journal ·R. James White, Karim El‐Kersh, Stephan Rosenkranz, Verónica Franco, Carmine Dario Vizza, Roberto Badagliacca, Joanna Pepke‐Żaba, Jean Elwing, Rahul Argula, Shelley Shapiro, Hyoshin Kim, (unknown), Eric Shen, Manisit Das, Meredith Broderick, (unknown)	1
3	Tyvaso DPI: Drug-device characteristics and patient clinical considerations 2023 ·Pulmonary Pharmacology & Therapeutics ·Colleen McEvoy, Rahul Argula, Sandeep Sahay, Shelley Shapiro, (unknown), Anthony J. Hickey, (unknown), (unknown), Thomas Winkler, Brittany N. Davis, Meredith Broderick, Charles D. Burger	5
4	Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial 2021 ·American Journal of Respiratory and Critical Care Medicine ·Steven D. Nathan, Victor F. Tapson, Jean Elwing, Franz Rischard, J.P. Mehta, Shelley Shapiro, Eric Shen, C. Q. Deng, Peter Smith, Aaron B. Waxman	44
5	Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System 2016 ·CHEST Journal ·Robert C. Bourge, Aaron B. Waxman, Mardi Gomberg‐Maitland, Shelley Shapiro, James Tarver, Dianne Zwicke, Jeremy P. Feldman, Murali M. Chakinala, Robert P. Frantz, Ferràn Torres, Jeffrey Cerkvenik, (unknown), (unknown), Leigh Peterson, Lewis J. Rubin	39
6	Study Design and Rationale for Investigating Phosphodiesterase type 5 Inhibition for the Treatment of Pulmonary Hypertension Due to Chronic Obstructive Lung Disease: The TADA‐PHiLD (TADAlafil for Pulmonary Hypertension Associated with Chronic Obstructive Lung Disease) Trial 2013 ·Pulmonary Circulation ·Bradley A. Maron, Ronald H. Goldstein, Sharon Rounds, Shelley Shapiro, Matthew Jankowich, Eric Garshick, Marilyn L. Moy, David Gagnon, Gaurav Choudhary	8
7	Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension 2012 ·Cardiovascular Therapeutics ·Robert C. Bourge, Victor F. Tapson, Zeenat Safdar, Raymond L. Benza, Richard N. Channick, Erika B. Rosenzweig, Shelley Shapiro, R.J. White, (unknown), (unknown), Andrew C. Nelsen, Lewis J. Rubin	29
8	Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies 2012 ·BMJ ·Brian Hutton, L. Joseph, Dean Fergusson, C. David Mazer, Shelley Shapiro, Alan Tinmouth	80
9	Catheter Ablation of Typical Atrial Flutter in Severe Pulmonary Hypertension 2012 ·Journal of Cardiovascular Electrophysiology ·Jason S. Bradfield, Shelley Shapiro, William Finch, Roderick Tung, Noel G. Boyle, Éric Buch, Nilesh Mathuria, Ravi Mandapati, Kalyanam Shivkumar, Malcolm Bersohn	23
10	Percutaneous intervention of left main coronary artery compression by pulmonary artery aneurysm 2010 ·Catheterization and Cardiovascular Interventions ·Marmar Vaseghi, Michael S. Lee, Jesse W. Currier, Jonathan M. Tobis, Shelley Shapiro, Jamil Aboulhosn	17
11	Tadalafil Therapy for Pulmonary Arterial Hypertension breakdown → 2009 ·Circulation ·Nazzareno Galiè, Bruce H. Brundage, Hossein Ardeschir Ghofrani, (unknown), Gérald Simonneau, Zeenat Safdar, Shelley Shapiro, R. James White, Melanie Chan, Anthony Beardsworth, Lyn R. Frumkin, Robyn J. Barst	794
12	Treatment of Pulmonary Arterial Hypertension With the Selective Endothelin-A Receptor Antagonist Sitaxsentan 2006 ·Journal of the American College of Cardiology ·Robyn J. Barst, David Langleben, David B. Badesch, Adaani Frost, E. Clinton Lawrence, Shelley Shapiro, Robert Naeije, Nazzareno Galiè	354
13	Ambrisentan Therapy for Pulmonary Arterial Hypertension 2005 ·Journal of the American College of Cardiology ·Nazzareno Galiè, David B. Badesch, Ronald J. Oudiz, Gérald Simonneau, Michael D. McGoon, Anne Keogh, Adaani Frost, Diane Zwicke, Robert Naeije, Shelley Shapiro, Horst Olschewski, Lewis J. Rubin	357
14	Sitaxsentan Therapy for Pulmonary Arterial Hypertension breakdown → 2003 ·American Journal of Respiratory and Critical Care Medicine ·Robyn J. Barst, David Langleben, Adaani Frost, Evelyn M. Horn, Ronald J. Oudiz, Shelley Shapiro, Vallerie V. McLaughlin, Nicholas S. Hill, Victor F. Tapson, Ivan M. Robbins, Diane Zwicke, Benjamin Duncan, Richard A. F. Dixon, Lyn R. Frumkin	540
15	Outcome after Cardiopulmonary Resuscitation in Patients with Pulmonary Arterial Hypertension 2002 ·American Journal of Respiratory and Critical Care Medicine ·Marius M. Hoeper, Nazzareno Galiè, Srinivas Murali, Horst Olschewski, Melvyn Rubenfire, (unknown), Harrison W. Farber, Vallerie V. McLaughlin, Shelley Shapiro, Joanna Pepke‐Żaba, J Winkler, Ralf Ewert, Christian Opitz, Volker Westerkamp, Jean-Luc Vachiéry, Adam Torbicki, J Behr, Robyn J. Barst	114
16	Responses to constant work rate bicycle ergometry exercise in primary pulmonary hypertension: the effect of inhaled nitric oxide 2000 ·Journal of the American College of Cardiology ·M. Riley, János Pórszász, M.P. Engelen, Shelley Shapiro, Bruce H. Brundage, (unknown)	36
17	Primary Pulmonary Hypertension: Improved Long-Term Effects and Survival With Continuous Intravenous Epoprostenol Infusion 1997 ·Journal of the American College of Cardiology ·Shelley Shapiro, Ronald J. Oudiz, (unknown), Matthew A. Romano, (unknown), (unknown), (unknown), Leonard E. Ginzton, Bruce H. Brundage	236
18	Long-term prognosis of patients with a normal exercise echocardiogram and clinical suspicion of myocardial ischemia 1995 ·The American Journal of Cardiology ·(unknown), (unknown), (unknown), Richard D. Conant, Shelley Shapiro, Leonard E. Ginzton	21
19	Influence of cardiac motion on Doppler measurements using in vitro and in vivo models 1993 ·Journal of the American College of Cardiology ·Tiesheng Cao, Shelley Shapiro, Malcolm Bersohn, (unknown), Leonard E. Ginzton	13
20	Predictive Risk Factors for Periannular Extension of Native Valve Endocarditis 1989 ·CHEST Journal ·Bassam Omari, Shelley Shapiro, Leonard E. Ginzton, John M. Robertson, Joel I. Ward, Ronald J. Nelson, Arnold S. Bayer	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact